INSIGHTS ON DRUG DEVELOPMENT

• Recombinant Protein Process Development And Scale-Up

  Discover a resin for recombinant protein purification with a standardized protocol that streamlines workflows from lab to production, which saves time and enhances efficiency across development stages.

• In Vitro Drug Screening On Cancer Cells

  Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.

• Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability

  A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

• Label-Free Analysis Of Multiple Spheroids In A Matrix

  Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.

• Accelerating Development With Rapid Delivery Of Toxicological Study Material

  3/19/2025

  Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.

• Take The Wheel And Drive Your Oligo Synthesis Where You Want

  2/9/2026

  Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.

• KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging

  9/18/2025

  Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.

• Streamline Drug Development With A Lab Informatics Platform

  8/13/2025

  Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.

• Nasal Delivery: Strategies For Success

  3/2/2026

  A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.